Literature DB >> 17484116

Tandem mass spectrometry in the detection of inborn errors of metabolism for newborn screening.

Frantisek Turecek1, C Ronald Scott, Michael H Gelb.   

Abstract

Tandem mass spectrometry has been used for determinations of enzyme activities in biological samples. Activities in rehydrated dried blood spots of lysosomal enzymes glucocerebrosidase, acid sphingomyelinase, galactocerebroside beta-galactosidase, acid-alpha-galactosidase, acid alpha-glucosidase, and alpha-D-iduronidase are measured simultaneously by multiple-reaction monitoring of ion dissociations from cations produced by electrospray ionization of enzymatic products. Simple and inexpensive assay protocols are described that are readily adopted for handling multiple samples in 96-well microtiter plates, employing simple separation steps, and using less than or equal to 3 micromol of synthetic or commercially available substrates, and less than 25 nmol of internal standards per analysis. The assays have the potential of being used for large-scale screening of newborns for the detection of inborn errors of metabolism.

Entities:  

Mesh:

Year:  2007        PMID: 17484116     DOI: 10.1007/978-1-59745-255-7_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

Review 1.  Newborn screening for neuropathic lysosomal storage disorders.

Authors:  Wuh-Liang Hwu; Yin-Hsiu Chien; Ni-Chung Lee
Journal:  J Inherit Metab Dis       Date:  2010-06-08       Impact factor: 4.982

2.  Direct tandem mass spectrometric profiling of sulfatides in dry urinary samples for screening of metachromatic leukodystrophy.

Authors:  Ladislav Kuchař; Befekadu Asfaw; Helena Poupětová; Jitka Honzíková; František Tureček; Jana Ledvinová
Journal:  Clin Chim Acta       Date:  2013-07-06       Impact factor: 3.786

3.  Protonation sites and dissociation mechanisms of t-butylcarbamates in tandem mass spectrometric assays for newborn screening.

Authors:  Zdeněk Spáčil; Renjie Hui; Michael H Gelb; František Tureček
Journal:  J Mass Spectrom       Date:  2011-10       Impact factor: 1.982

4.  Gene therapy for cardiovascular manifestations of lysosomal storage diseases.

Authors:  Meg M Sleeper; Mark E Haskins; Katherine P Ponder
Journal:  Heart Metab       Date:  2008

5.  Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).

Authors:  Trisha A Duffey; Martin Sadilek; C Ronald Scott; Frantisek Turecek; Michael H Gelb
Journal:  Anal Chem       Date:  2010-10-20       Impact factor: 6.986

6.  Comparative triplex tandem mass spectrometry assays of lysosomal enzyme activities in dried blood spots using fast liquid chromatography: application to newborn screening of Pompe, Fabry, and Hurler diseases.

Authors:  Zdeněk Spáčil; Susan Elliott; Steven L Reeber; Michael H Gelb; C Ronald Scott; František Tureček
Journal:  Anal Chem       Date:  2011-05-17       Impact factor: 6.986

7.  A tandem mass spectrometry triplex assay for the detection of Fabry, Pompe, and mucopolysaccharidosis-I (Hurler).

Authors:  Trisha A Duffey; Garland Bellamy; Susan Elliott; Angela C Fox; Michael Glass; Frantisek Turecek; Michael H Gelb; C Ronald Scott
Journal:  Clin Chem       Date:  2010-10-12       Impact factor: 8.327

8.  Direct assay of enzymes in heme biosynthesis for the detection of porphyrias by tandem mass spectrometry. Uroporphyrinogen decarboxylase and coproporphyrinogen III oxidase.

Authors:  Yuesong Wang; Paula Gatti; Martin Sadílek; C Ronald Scott; Frantisek Turecek; Michael H Gelb
Journal:  Anal Chem       Date:  2008-02-23       Impact factor: 6.986

Review 9.  Newborn screening and diagnosis of mucopolysaccharidoses.

Authors:  Shunji Tomatsu; Tadashi Fujii; Masaru Fukushi; Toshihiro Oguma; Tsutomu Shimada; Miho Maeda; Kazuhiro Kida; Yuniko Shibata; Hideyuki Futatsumori; Adriana M Montaño; Robert W Mason; Seiji Yamaguchi; Yasuyuki Suzuki; Tadao Orii
Journal:  Mol Genet Metab       Date:  2013-06-21       Impact factor: 4.797

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.